Leukemia Research
Volume 30, Issue 2 , Pages 178-182, February 2006

Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy

Received 26 May 2005; accepted 26 June 2005. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00257-2

doi:10.1016/j.leukres.2005.06.015

Leukemia Research
Volume 30, Issue 2 , Pages 178-182, February 2006

Article Tools